11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 315 / 薬物数 : 232 - (DrugBank : 77) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 126

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04226170 (ClinicalTrials.gov)	April 8, 2021	9/1/2020	Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis	A Phase II, Study to Evaluate the Safety and Tolerability of PyridostigmineWhen Given With Ondansetr ...	Myasthenia Gravis	Drug: DAS-001	DAS-MG, Inc	NULL	Recruiting	18 Years	N/A	All	24	Phase 2	United States
2	NCT04768465 (ClinicalTrials.gov)	January 1, 2021	21/2/2021	Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis	Effectiveness and Safety of Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia ...	Myasthenia Gravis	Drug: Pyridostigmine , Prednisone, Tacrolimus;Drug: Pyridostigmine , Tacrolimus	Da, Yuwei, M.D.	NULL	Recruiting	18 Years	N/A	All	160		China
3	NCT03510546 (ClinicalTrials.gov)	April 9, 2018	6/4/2018	Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis	Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis	Myasthenia Gravis	Drug: Pyridostigmine;Drug: Placebo oral capsule	University of Aarhus	Aarhus University Hospital	Recruiting	18 Years	90 Years	All	44	Phase 4	Denmark
4	EUCTR2017-002599-15-DK (EUCTR)	07/11/2017	07/07/2017	Effect of pyridostigmine (Mestinon®) on muscle strength in Myasthenia Gravis.	Effect of pyridostigmine (Mestinon®) on muscle strength in Myasthenia Gravis.	Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Myasthenia grav ...	Trade Name: Mestinon INN or Proposed INN: pyridostigmine Other descriptive name: PYRIDOSTIGMINE	Aarhus University	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	32	Phase 4	Denmark
5	ChiCTR-TRC-13004125	2010-10-01	2013-06-08	The study on the pathogenesis of spleen-kidney deficiency type myasthenia gravis and the interferenc ...	The study on the pathogenesis of spleen-kidney deficiency type myasthenia gravis and the interferenc ...	Myasthenia gravis	trial:Jianji Ning Granule combined with olfactory pyridostigminetablets ;Control:olfactory pyridosti ...	Longhua Hospital Affiliated to Shanghai University of traditional Chinese Medicine	NULL	Completed	14	75	Both	trial:30;Control:30;	I+2 (Phase 1+Phase 2)	China

First Previous1Next Last